DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
+11.35%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$451M
AUM Growth
+$451M
(+0.71%)
Cap. Flow
-$23.9M
Cap. Flow
% of AUM
-5.29%
Top 10 Holdings %
Top 10 Hldgs %
34.82%
Holding
113
New
12
Increased
22
Reduced
44
Closed
8
Top Buys
| 1 |
Applied Materials
AMAT
|
$7.53M |
| 2 |
American Tower
AMT
|
$7.03M |
| 3 |
Netflix
NFLX
|
$6.84M |
| 4 |
Affiliated Managers Group
AMG
|
$6.25M |
| 5 |
Avery Dennison
AVY
|
$6.24M |
Top Sells
| 1 |
BCR
CR Bard Inc.
BCR
|
$11.3M |
| 2 |
Quest Diagnostics
DGX
|
$8.65M |
| 3 |
Meta Platforms (Facebook)
META
|
$8.25M |
| 4 |
Ulta Beauty
ULTA
|
$8.12M |
| 5 |
Amazon
AMZN
|
$7.12M |
Sector Composition
| 1 | Technology | 36.56% |
| 2 | Healthcare | 24.42% |
| 3 | Communication Services | 8.23% |
| 4 | Financials | 8.22% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$139B
| $2.55M | 0.57% |
31,475
-200
| -0.6% | -$16.2K |
|
52
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.53M | 0.56% |
13,800
-100
| -0.7% | -$18.3K |
|
53
Tactile Systems Technology
TCMD
$299M
| $2.15M | 0.48% |
+69,500
| New | +$2.15M |
|
54
Atmos Energy
ATO
$26.6B
| $2.13M | 0.47% |
25,400
| – | – |
|
55
Zions Bancorporation
ZION
$8.34B
| $2.08M | 0.46% |
44,000
+8,500
| +24% | +$401K |
|
56
Edwards Lifesciences
EW
$47.9B
| $2.07M | 0.46% |
18,900
-100
| -0.5% | -$10.9K |
|
57
Masimo
MASI
$7.38B
| $2M | 0.44% |
23,100
-2,150
| -9% | -$186K |
|
58
Inogen
INGN
$219M
| $1.83M | 0.4% |
+19,200
| New | +$1.83M |
|
59
Crown Castle
CCI
$42.9B
| $1.81M | 0.4% |
18,150
+2,050
| +13% | +$205K |
|
60
Verizon
VZ
$185B
| $1.67M | 0.37% |
33,718
-600
| -2% | -$29.7K |
|
|
SIVB
61
DELISTED
SVB Financial Group
SIVB
| $1.67M | 0.37% |
+8,900
| New | +$1.67M |
|
|
62
Ulta Beauty
ULTA
$23.6B
| $1.65M | 0.37% |
7,300
-35,940
| -83% | -$8.12M |
|
63
AT&T
T
$209B
| $1.45M | 0.32% |
37,097
| – | – |
|
|
ESRX
64
DELISTED
Express Scripts Holding Company
ESRX
| $1.32M | 0.29% |
20,900
-12,032
| -37% | -$762K |
|
65
Citigroup
C
$173B
| $1.28M | 0.28% |
17,582
-200
| -1% | -$14.5K |
|
66
General Mills
GIS
$26.4B
| $1.27M | 0.28% |
24,600
| – | – |
|
67
3M
MMM
$81.8B
| $1.15M | 0.26% |
5,500
+100
| +2% | +$21K |
|
68
Neurocrine Biosciences
NBIX
$14B
| $1.08M | 0.24% |
17,700
-4,650
| -21% | -$285K |
|
69
BCE
BCE
$22.9B
| $1.04M | 0.23% |
22,111
| – | – |
|
70
Healthpeak Properties
DOC
$12.4B
| $1.01M | 0.22% |
36,250
-300
| -0.8% | -$8.34K |
|
71
Procter & Gamble
PG
$372B
| $1M | 0.22% |
11,002
| – | – |
|
72
Analog Devices
ADI
$121B
| $999K | 0.22% |
11,600
-8,000
| -41% | -$689K |
|
|
CMD
73
DELISTED
Cantel Medical Corporation
CMD
| $998K | 0.22% |
10,600
-200
| -2% | -$18.8K |
|
74
Reinsurance Group of America
RGA
$12.8B
| $990K | 0.22% |
7,100
-3,600
| -34% | -$502K |
|
|
XL
75
DELISTED
XL Group Ltd.
XL
| $978K | 0.22% |
24,800
-93,600
| -79% | -$3.69M |
|